![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, pr... Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.026 | -6.84210526316 | 0.38 | 0.385 | 0.3501 | 33483 | 0.36609233 | CS |
4 | -0.0256 | -6.74394099052 | 0.3796 | 0.4 | 0.3371 | 61805 | 0.36407165 | CS |
12 | -0.256 | -41.9672131148 | 0.61 | 0.632 | 0.333 | 91910 | 0.41985753 | CS |
26 | -0.636 | -64.2424242424 | 0.99 | 0.99 | 0.333 | 96752 | 0.56990504 | CS |
52 | -0.636 | -64.2424242424 | 0.99 | 0.99 | 0.333 | 96752 | 0.56990504 | CS |
156 | -0.636 | -64.2424242424 | 0.99 | 0.99 | 0.333 | 96752 | 0.56990504 | CS |
260 | -0.636 | -64.2424242424 | 0.99 | 0.99 | 0.333 | 96752 | 0.56990504 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions